The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 28.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.571%)
Open: 28.50
High: 28.50
Low: 28.50
Prev. Close: 28.50
PEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Update

9 Aug 2019 07:00

RNS Number : 5273I
Pennant International Group PLC
09 August 2019
 

FOR IMMEDIATE RELEASE 9 August 2019

PENNANT INTERNATIONAL GROUP PLC

 

Pre-Close Trading Update

 

Notice of 2019 Interim Results

 

 

Pennant International Group plc ("Pennant", the "Group", or the "Company"), the AIM quoted supplier of integrated training and support solutions, products and services which train and assist operators and maintainers in the defence and regulated civilian sectors, announces the following trading update ahead of the publication of its Interim Results for the six months ended 30 June 2019 (the "First Half", or "H1 2019") which are scheduled to be released on 24 September 2019.

 

The Company stated in its 2018 Annual Report (published in March 2019) that it expected 2019 to be significantly weighted in favour of the second half of the year (the "Second Half", or "H2 2019"), with the majority of revenues for the year (and all profits) anticipated to be realised in H2 2019 upon the achievement of certain performance milestones on the Qatar contract.

 

The Company expects to report results for the First Half which are slightly better than management's expectations, with revenues of £7.25 million and an EBITA loss of £(1.49) million. Net cash stood at approximately £(0.35) million at the end of H1 2019.

 

Contracts Update

 

The Group continues to make good progress on the Qatar contract and is 'on track' to meet the relevant performance milestones mentioned above to enable it to recognise the revenues and profits which are budgeted for the contract for H2 2019.

 

On its contract for electro-mechnical trainers for the Ajax armoured fighting vehicle, the Group is currently in the process of assessing and responding to a customer request for additional and amended functionality for the training devices. Initial assessment of this request has identified that the programme schedule may need to be extended, and it is now anticipated that progress on delivering the contract may be slower than budgeted for the Second Half, with material uplift in revenues not envisaged until the contract is re-based towards the year-end.

 

The Group's other main programme, its long-standing contract with the Canadian Department for National Defence, is delivering to budget.

 

The Group's three-year contracted order book stood at £36 million at the end of the First Half.

 

Pipeline

 

The Group expects the contract for the 'Major Programme' (as previously announced on 9 August 2018) to be awarded to it during 2020 and is in dialogue with the customer about schedule and early delivery to Pennant of certain assets required for the programme. The Group continues to carry certain additional costs in anticipation of this contract and other larger-scale potential contracts (e.g. costs in relation to upgraded infrastructure and retention of key resources).

 

This enhanced operational capability remains important as the Company is prospective sole-source supplier on a number of significant opportunities expected to convert into contracts during the next 6 to 12 months, the aggregate value of which (including the Major Programme) is in excess of £36 million. The timing as to if and when these contracts are awarded is, of course, beyond Pennant's control, and (in the case of those ultimately derived from UK defence requirements) may be impacted by the continued uncertainty surrounding Brexit (although this has not been formally confirmed).

 

A number of smaller potential orders that had been expected to convert in H2 2019 now appear more likely to be realised next year, which adds to the Group's healthy pipeline for 2020.

 

Strategy

 

The Board remains confident about the Company's prospects. It has always recognised that the Company's core 'training systems' business is susceptible to long, uncertain gestation periods for contract awards and to schedule revisions on its engineered-to-order programmes.

 

It is this recognition that has underpinned the Board's drive to diversify the business to increase the proportion of recurring revenues from software and services. Steps taken during the First Half towards that objective include the acquisition of the Aviation Skills Partnership and Track Access Services, which have brought training delivery opportunity and software subscription revenues respectively to the Group.

 

The Track Access Services business has been integrated into the Group and is undertaking 'business as usual'. However, the expansion of the Aviation Skills Partnership business is taking longer than initially expected, primarily due to decisions regarding the allocation of public funding of projects being delayed due to the current focus on Brexit. The revenue-generating activities associated with the initial phase of such projects, budgeted for 2019, have not therefore occurred as anticipated and will move into 2020.

Other strategic opportunities are actively being progressed, each with software and services as a key component.

 

Outlook

 

With the change to revenue expectations on the Ajax programme and in the Aviation Skills Partnership business, together with the timeline for the award of certain potential contracts moving into 2020, the Group now expects its results for 2019 to be materially lower than current market expectations and anticipates reporting EBITA for 2019 as a whole of £1.8 million. The Group has more than adequate working capital facilities for the next period and beyond.

 

The Group's costs reduction exercise in response to the delay to the award of the Major Programme (as explained in the Company's announcement on 2 May 2019) is ongoing, although the benefits of this exercise will have limited impact on the Second Half.

 

The Group is actively pursuing other potential revenue opportunities (in addition to those referred to above) and, depending on the timing of their conclusion, certain of these may be realised within time to positively impact 2019. A further update on these matters will be provided upon publication of the Interim Results.

 

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director

+44 (0) 1452 714 914

 

 

WH Ireland Limited (Nomad and Broker)

www.whirelandcb.com

Mike Coe

Chris Savidge

+44 (0) 117 945 3470

 

 

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTCKCDNPBKKQFK
Date   Source Headline
24th Apr 20242:44 pmRNSNotice of Results and Appointment of Board Adviser
7th Feb 20247:00 amRNSAppointment of Non-executive Director
7th Feb 20247:00 amRNSYear-End Trading Update
22nd Nov 202311:41 amRNSHolding(s) in Company
15th Nov 20235:20 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20237:00 amRNSNew Strategic Partnership
7th Sep 20237:00 amRNSPennant attending DSEI, London
19th Jul 20237:00 amRNSTrading Update & Notice of Interim Results
10th Jul 202310:39 amRNSIssue of Equity, Director Dealings & TVR
13th Jun 20237:00 amRNSBusiness Update: New Contract Wins
7th Jun 202310:40 amRNSResult of AGM
23rd May 202310:45 amRNSHolding in Company
22nd May 20233:15 pmRNSHolding in Company
16th May 202312:21 pmRNSHolding in Company
27th Apr 202311:31 amRNSNotice of AGM & Posting of 2022 Annual Accounts
26th Apr 20237:00 amRNS2022 Final Results
20th Apr 20237:00 amRNSNotice of 2022 Final Results
13th Apr 20237:00 amRNSAcquisition of UK Rail Services Business
16th Mar 20232:00 pmRNSHolding(s) in Company
14th Mar 20235:30 pmRNSHolding(s) in Company
23rd Feb 20231:13 pmRNSAppointment of Chair
8th Feb 202311:05 amRNSSecond Price Monitoring Extn
8th Feb 202311:00 amRNSPrice Monitoring Extension
8th Feb 20237:00 amRNSYear-end Trading Update
19th Jan 20239:31 amRNSHolding(s) in Company
12th Jan 202312:47 pmRNSAppointment of Director
9th Nov 20227:00 amRNSShare Option Restructuring
24th Oct 20228:31 amRNSDirectorate Change
21st Sep 20227:00 amRNS2022 Interim Results
9th Aug 20225:51 pmRNSIssue of Equity, Director/PDMR Dealings & TVR
9th Aug 202210:32 amRNSHoldings in Company
3rd Aug 20227:00 amRNSSale of Pennant Court
28th Jul 20227:00 amRNSTrading Update & Notice of Interim Results
30th Jun 20227:00 amRNSNotice of Capital Markets Day
22nd Jun 202210:27 amRNSResult of AGM
27th May 202210:56 amRNSNotice of AGM
25th May 20227:00 amRNS2021 Final Results
29th Apr 20227:00 amRNSNotice of Final Results
19th Apr 20221:42 pmRNSHolding in Company
6th Apr 20227:00 amRNSIssue of Equity, Director/PDMR Dealings & TVR
23rd Mar 20227:00 amRNSContracts & Order Book Update
21st Jan 202210:19 amRNSMajor Programme Update
20th Jan 20229:05 amRNSSecond Price Monitoring Extn
20th Jan 20229:00 amRNSPrice Monitoring Extension
20th Jan 20227:00 amRNSTrading Update
16th Dec 202110:55 amRNSHolding in Company
3rd Dec 202111:20 amRNSMajor Programme Update
17th Nov 202112:04 pmRNSHolding in Company
11th Nov 20215:13 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.